Predictive properties of plasma amino acid profile for cardiovascular disease in patients with type 2 diabetes

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Kume, Shinji ^a   Araki, Shin Ichi ^a   Ono, Nobukazu ^b   Shinhara, Atsuko ^b   Muramatsu, Takahiko ^b   Araki, Hisazumi ^a   Isshiki, Keiji ^a   Nakamura, Kazuki ^b   Miyano, Hiroshi ^b   Koya, Daisuke ^c   Haneda, Masakazu ^d   Ugi, Satoshi ^a   Kawai, Hiromichi ^a   Kashiwagi, Atsunori ^a   Uzu, Takashi ^a   Maegawa, Hiroshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b AJINOMOTO CO INC   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOBUTYRIC ACID; 3 AMINO 2 METHYLPROPIONIC ACID; 3 METHYLHISTIDINE; ALBUMIN; ALPHA AMINO ADIPIC ACID; AMINO ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; CITRULLINE; CYSTINE; ETHANOLAMINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; HYDROXYPROLINE; ISOLEUCINE; METHIONINE; ORNITHINE; PHENYLALANINE; PRORINE; SARCOSINE; SERINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG; VALINE; BIOLOGICAL MARKER;

ADULT; AGED; ALBUMINURIA; AMINO ACID BLOOD LEVEL; ANGINA PECTORIS; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; URINARY EXCRETION; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COMPLICATION; EVALUATION STUDY; MIDDLE AGED; PREDICTIVE VALUE;

AGED; AMINO ACIDS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 84903373757     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101219     Document Type: Article

References (23)

1. American Diabetes Association (2013) Standards of Medical Care in Diabetes-2013. Diabetes Care 36: S11-S66.
2. Gaede P, Vedel P, Larsen N, Jensen GV, Prving HH, et al. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New Engl J Med 348: 383-393. (Pubitemid 36159355)
3. Araki S, Haneda M, Koya D, Hidaka H, Sugimoto T, et al. (2007) Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes. Diabetes 56: 1727-1730. (Pubitemid 46842621)
4. Schmieder RE, Mann JF, Schumacher H, Gao P, Mancia G, et al ONTARGET Investigators (2011) Changes in albuminuria predict mortality and morbidity in patients with vascular disease. J Am Soc Nephrol 22: 1353-1364.
5. Yokoyama H, Araki S, Haneda M, Matsushima M, Kawai K, et al Japan Diabetes Clinical Data Management Study Group (2012) Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25). Diabetologia 55: 1911-1918.
6. Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, et al. (2005) Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 54: 2983-2987. (Pubitemid 41401096)
7. Yokoyama H, Araki S, Honjo J, Okizaki S, Yamada D, et al. (2013) Association between remission of macroalbuminuria and preservation of renal function in patients with type 2 diabetes with overt proteinuria. Diabetes Care 36: 3227-3233.
8. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, et al. (2009) Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 58: 2429-2443.
9. McKillop AM, Flatt PR (2011) Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine. Diabetes Care 34: 2624-2630.
10. Shah SH, Kraus WE, Newgard CB (2012) Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation 126: 1110-20.
11. Benjamin DI, Cravatt BF, Nomura DK (2012) Global profiling strategies for mapping dysregulated metabolic pathways in cancer. Cell Metab 16: 565-577.
12. Kimura T, Noguchi Y, Shikata N, Takahashi M (2009) Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks. Curr Opin Clin Nutr Metab Care 12: 49-53.
13. Shimbo K, Yahashi A, Hirayama K, Nakazawa M, Miyano H (2009) Multifunctional and highly sensitive precolumn reagents for amino acids in liquid chromatography/tandem mass spectrometry. Anal Chem 81: 5172-5179.
14. Miyagi Y, Higashiyama M, Gochi A, Akaike M, Ishikawa T, et al. (2011) Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS One 6: e24143.
15. Araki S, Haneda M, Koya D, Sugaya T, Isshiki K, et al. (2013) Predictive effects of urinary liver-type fatty-acid binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy. Diabetes Care 36: 1248-1253.
16. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al, Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992.
17. The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus (2010) Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 1: 212-228.
18. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, et al. (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17: 448-453.
19. Magnusson M, Lewis GD, Ericson U, Orho-Melander M, Hedblad B, et al. (2013) A diabetes-predictive amino acid score and future cardiovascular disease. Eur Heart J 34: 1982-1989.
20. Shah SH, Bain JR, Muehlbauer MJ, Stevens RD, Crosslin DR, et al. (2010) Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet 3: 207-214.
21. Shah SH, Sun JL, Stevens RD, Bain JR, Muehlbauer MJ, et al. (2012) Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am Heart J 163: 844-850.
22. Shah SH, Hauser ER, Bain JR, Muehlbauer MJ, Haynes C, et al. (2009) High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol 5: 258-266.
23. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, et al. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-326.